Back to results
US 2011/0217755 A1Published application
Variant form of urate oxidase and use thereof
AssigneeSavient Pharmaceuticals, Inc.
InventorsJacob Hartman, Simona Mendelovitz
Life of this patent
Estimating the term…
Abstract
The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
Claims6
1-4. (canceled)
An isolated uricase comprising the amino acid sequence of position 8 through position 287 of SEQ ID NO. 12.
9-15. (canceled)
Dependencies are inferred from the claim text.